Six trials totaling roughly 900 participants are summarized in Stier et al
Tendon and tissue healing: animal studies have examined tendon, muscle, and wound models, which is why the peptide appears in recovery-focused research
Based on the REDEFINE 1 trial protocol, the standard dosing schedule progresses over 20 weeks to reach maximum maintenance levels [3]
The critical gap: There are no published human clinical trials examining BPC-157 for depression, anxiety, or any psychiatric condition
Its interaction with the nitric oxide system is bidirectional: BPC-157 counteracts both NO-synthase inhibition and excessive NO release, effectively functioning as a stabilizer of the NO system rather than a simple agonist or antagonist
Delve into B12 Shots & Injections: The Good, Bad, and Alternative